Cargando…

Utility of DNA Methylation as a Biomarker in Aging and Alzheimer’s Disease

Epigenetic mechanisms such as DNA methylation have been implicated in a number of diseases including cancer, heart disease, autoimmune disorders, and neurodegenerative diseases. While it is recognized that DNA methylation is tissue-specific, a limitation for many studies is the ability to sample the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milicic, Lidija, Porter, Tenielle, Vacher, Michael, Laws, Simon M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259073/ https://www.ncbi.nlm.nih.gov/pubmed/37313495 http://dx.doi.org/10.3233/ADR-220109

Ejemplares similares

Sixteen-Year Longitudinal Evaluation of Blood-Based DNA Methylation Biomarkers for Early Prediction of Alzheimer’s Disease
por: Schäfer Hackenhaar, Fernanda, et al.
Publicado: (2023)

Assessment of a polygenic hazard score for the onset of pre-clinical Alzheimer’s disease
por: Vacher, Michael, et al.
Publicado: (2022)

Validation of a priori candidate Alzheimer’s disease SNPs with brain amyloid-beta deposition
por: Vacher, Michael, et al.
Publicado: (2019)

Sleep, Sirtuin 1 and Alzheimer’s disease: A review
por: Mehramiz, Mehrane, et al.
Publicado: (2022)

A Potential Role for Sirtuin-1 in Alzheimer’s Disease: Reviewing the Biological and Environmental Evidence
por: Mehramiz, Mehrane, et al.
Publicado: (2023)

Current Insights on the Use of Insulin and the Potential Use of Insulin Mimetics in Targeting Insulin Signalling in Alzheimer’s Disease
por: Woodfield, Amy, et al.
Publicado: (2022)

Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume
por: Milicic, Lidija, et al.
Publicado: (2022)

Relationship of Cognition and Alzheimer’s Disease with Gastrointestinal Tract Disorders: A Large-Scale Genetic Overlap and Mendelian Randomisation Analysis
por: Adewuyi, Emmanuel O., et al.
Publicado: (2022)

A large-scale genome-wide cross-trait analysis reveals shared genetic architecture between Alzheimer’s disease and gastrointestinal tract disorders
por: Adewuyi, Emmanuel O., et al.
Publicado: (2022)

Hair and salivary cortisol and their relationship with lifestyle, mood and cognitive outcomes in premanifest Huntington’s disease
por: Cruickshank, Travis, et al.
Publicado: (2021)

A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer’s Disease
por: Porter, Tenielle, et al.
Publicado: (2018)

DNA methylation alterations in Alzheimer’s disease
por: Yokoyama, Amy S., et al.
Publicado: (2017)

Discovery of a Missense Mutation (Q222K) of the APOE Gene from the Australian Imaging, Biomarker and Lifestyle Study
por: Roberts, Blaine R., et al.
Publicado: (2023)

DNA Methylation Biomarkers in Aging and Age-Related Diseases
por: Salameh, Yasmeen, et al.
Publicado: (2020)

The Effects of Latrepirdine on Amyloid-β Aggregation and Toxicity
por: Porter, Tenielle, et al.
Publicado: (2016)

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers
por: Lee, Jinny Claire, et al.
Publicado: (2019)

Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects
por: Zhang, Wei, et al.
Publicado: (2023)

Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects
por: Zhang, Wei, et al.
Publicado: (2023)

Utility of Blood-Based Tau Biomarkers for Mild Cognitive Impairment and Alzheimer’s Disease: Systematic Review and Meta-Analysis
por: Zabala-Findlay, Alex, et al.
Publicado: (2023)

Genetic variation in Aquaporin-4 moderates the relationship between sleep and brain Aβ-amyloid burden
por: Rainey-Smith, Stephanie R., et al.
Publicado: (2018)

Biomarkers Predicting Alzheimer's Disease in Cognitively Normal Aging
por: Shim, Yong S., et al.
Publicado: (2011)

Exploring discordant low amyloid beta and high neocortical tau positron emission tomography cases
por: Krishnadas, Natasha, et al.
Publicado: (2022)

Reflections on the Utility of the Retina as a Biomarker for Alzheimer’s Disease: A Literature Review
por: Ngolab, Jennifer, et al.
Publicado: (2019)

DNA Methylation Biomarkers: Cancer and Beyond
por: Mikeska, Thomas, et al.
Publicado: (2014)

KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE ε4-positive cognitively normal adults with high Aβ-amyloid burden
por: Porter, Tenielle, et al.
Publicado: (2018)

Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging
por: Gupta, Veer Bala, et al.
Publicado: (2015)

COMT val158met is not associated with Aβ-amyloid and APOE ε4 related cognitive decline in cognitively normal older adults
por: Porter, Tenielle, et al.
Publicado: (2019)

Common DNA methylation alterations of Alzheimer's disease and aging in peripheral whole blood
por: Li, Hongdong, et al.
Publicado: (2016)

Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer’s Disease
por: Fowler, Christopher, et al.
Publicado: (2021)

Peripheral biomarkers of oxidative stress in aging and Alzheimer’s disease
por: Marcourakis, Tania, et al.
Publicado: (2008)

Neuroimaging Biomarkers for Alzheimer’s Disease
por: Márquez, Freddie, et al.
Publicado: (2019)

The role of DNA methylation in epigenetics of aging
por: Unnikrishnan, Archana, et al.
Publicado: (2018)

Investigating the relationship between DNA methylation age acceleration and risk factors for Alzheimer's disease
por: McCartney, Daniel L., et al.
Publicado: (2018)

Abnormal Homocysteine Metabolism: An Insight of Alzheimer's Disease from DNA Methylation
por: Pi, Tingting, et al.
Publicado: (2020)

DNA methylation and healthy human aging
por: Jones, Meaghan J., et al.
Publicado: (2015)

Risk prediction of late-onset Alzheimer’s disease implies an oligogenic architecture
por: Zhang, Qian, et al.
Publicado: (2020)

Epigenetic signatures of methylated DNA cytosine in Alzheimer’s disease
por: Fetahu, Irfete S., et al.
Publicado: (2019)

SPON1 Is Associated with Amyloid-β and APOE ε4-Related Cognitive Decline in Cognitively Normal Adults
por: Fernandez, Shane, et al.
Publicado: (2021)

DNA Methylation: A Promising Approach in Management of Alzheimer’s Disease and Other Neurodegenerative Disorders
por: Kaur, Gagandeep, et al.
Publicado: (2022)

Biomarkers in Alzheimer’s disease
por: Janeiro, Manuel H., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9g8nnnjkqqs8ua6eh7kogve4us